DI > Ekonomi

Torsdag, 12 November, 12:33

DI02 jun 23 kl. 12:56

STENOCARE reports on significant progress in development of its new innovative medical cannabis product

Socialdemokraterna (Sverige)
Socialdemokraterna (Sverige) · Foto: Wikimedia Commons


STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER:  STENO STENOCARE A/S (“Stenocare”) has selected an international, highly experienced partner to produce a new and innovative medical cannabis oil product, that has the potential to revolutionize the industry and offer patients improved treatment effect. The new product is based on a patented oil technology, that Stenocare has global exclusivity to use for medical cannabis..
Läs mer på DI
Dela artikeln Facebook X LinkedIn E-post

Fördjupa dig

Fler nyheter från DI

DI41 min sedan

Chipbolaget mer än dubblar resultatet

Den kinesiska kontraktstillverkaren av halvledare Semiconductor Manufacturing International (SMIC) mer än fördubblade resultatet i det tredje kvartalet 2026. Nettoresultatet steg till 428 miljoner dollar, upp från 192 mi…